Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Correction: Development and validation of a novel risk score for the detection of insignificant prostate cancer in unscreened patient cohorts.

Dutto L, Ahmad A, Urbanova K, Wagner C, Schuette A, Addali M, Kelly JD, Sridhar A, Nathan S, Briggs TP, Witt JH, Shaw GL.

Br J Cancer. 2019 Apr;120(7):771. doi: 10.1038/s41416-019-0408-7.

2.

VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.

Bailey C, Bourne RM, Siow B, Johnston EW, Brizmohun Appayya M, Pye H, Heavey S, Mertzanidou T, Whitaker H, Freeman A, Patel D, Shaw GL, Sridhar A, Hawkes DJ, Punwani S, Alexander DC, Panagiotaki E.

NMR Biomed. 2019 May;32(5):e4073. doi: 10.1002/nbm.4073. Epub 2019 Feb 19.

3.

Development and validation of a novel risk score for the detection of insignificant prostate cancer in unscreened patient cohorts.

Dutto L, Ahmad A, Urbanova K, Wagner C, Schuette A, Addali M, Kelly JD, Sridhar A, Nathan S, Briggs TP, Witt JH, Shaw GL.

Br J Cancer. 2018 Dec;119(12):1445-1450. doi: 10.1038/s41416-018-0316-2. Epub 2018 Nov 27. Erratum in: Br J Cancer. 2019 Apr;120(7):771.

PMID:
30478408
4.

A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer.

Warren AY, Massie CE, Watt K, Luko K, Orafidiya F, Selth LA, Mohammed H, Chohan BS, Menon S, Baridi A, Zhao W, Escriu C, Pungsrinont T, D'Santos C, Yang X, Taylor C, Qureshi A, Zecchini VR, Shaw GL, Dehm SM, Mills IG, Carroll JS, Tilley WD, McEwan IJ, Baniahmad A, Neal DE, Asim M.

Oncogene. 2019 Feb;38(7):1136-1150. doi: 10.1038/s41388-018-0501-z. Epub 2018 Sep 20.

5.

Apparatus for Histological Validation of In Vivo and Ex Vivo Magnetic Resonance Imaging of the Human Prostate.

Bourne RM, Bailey C, Johnston EW, Pye H, Heavey S, Whitaker H, Siow B, Freeman A, Shaw GL, Sridhar A, Mertzanidou T, Hawkes DJ, Alexander DC, Punwani S, Panagiotaki E.

Front Oncol. 2017 Mar 24;7:47. doi: 10.3389/fonc.2017.00047. eCollection 2017.

6.

Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial.

Johnston TJ, Shaw GL, Lamb AD, Parashar D, Greenberg D, Xiong T, Edwards AL, Gnanapragasam V, Holding P, Herbert P, Davis M, Mizielinsk E, Lane JA, Oxley J, Robinson M, Mason M, Staffurth J, Bollina P, Catto J, Doble A, Doherty A, Gillatt D, Kockelbergh R, Kynaston H, Prescott S, Paul A, Powell P, Rosario D, Rowe E, Donovan JL, Hamdy FC, Neal DE; ProtecT study group.

Eur Urol. 2017 Mar;71(3):381-388. doi: 10.1016/j.eururo.2016.09.040. Epub 2016 Oct 6.

7.

Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.

Thomas BC, Kay JD, Menon S, Vowler SL, Dawson SN, Bucklow LJ, Luxton HJ, Johnston T, Massie CE, Pugh M, Warren AY, Barker P, Burling K, Lynch AG, George A, Burge J, Corcoran M, Stearn S, Lamb AD, Sharma NL, Shaw GL, Neal DE, Whitaker HC.

Endocr Relat Cancer. 2016 Oct;23(10):797-812. doi: 10.1530/ERC-16-0287. Epub 2016 Aug 30.

PMID:
27578825
8.

Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy.

Madhu B, Shaw GL, Warren AY, Neal DE, Griffiths JR.

Metabolomics. 2016;12:120. Epub 2016 Jun 30.

9.

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.

Shaw GL, Whitaker H, Corcoran M, Dunning MJ, Luxton H, Kay J, Massie CE, Miller JL, Lamb AD, Ross-Adams H, Russell R, Nelson AW, Eldridge MD, Lynch AG, Ramos-Montoya A, Mills IG, Taylor AE, Arlt W, Shah N, Warren AY, Neal DE.

Eur Urol. 2016 Aug;70(2):214-8. doi: 10.1016/j.eururo.2015.10.042. Epub 2015 Nov 10.

10.

Late Imaging with [1-(11)C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET.

Lewis DY, Boren J, Shaw GL, Bielik R, Ramos-Montoya A, Larkin TJ, Martins CP, Neal DE, Soloviev D, Brindle KM.

J Nucl Med. 2014 Jul;55(7):1144-9. doi: 10.2967/jnumed.113.134437. Epub 2014 Apr 28.

11.

HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network.

Ramos-Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano-Dalmau N, Massie CE, Boren J, Bon H, Theodorou V, Vias M, Shaw GL, Sharma NL, Ross-Adams H, Scott HE, Vowler SL, Howat WJ, Warren AY, Wooster RF, Mills IG, Neal DE.

EMBO Mol Med. 2014 May;6(5):651-61. doi: 10.1002/emmm.201303581.

12.

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.

Shaw GL, Thomas BC, Dawson SN, Srivastava G, Vowler SL, Gnanapragasam VJ, Shah NC, Warren AY, Neal DE.

Br J Cancer. 2014 May 13;110(10):2405-11. doi: 10.1038/bjc.2014.192. Epub 2014 Apr 10.

13.

Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.

Shaw GL, Hussain M, Nair R, Bycroft J, Beltran L, Green JS, Powles T, Peters JL.

Urol Int. 2012;89(1):83-8. doi: 10.1159/000338057. Epub 2012 May 16.

14.

The role of surgery in high-risk localised prostate cancer.

Gnanapragasam VJ, Mason MD, Shaw GL, Neal DE.

BJU Int. 2012 Mar;109(5):648-58. doi: 10.1111/j.1464-410X.2011.10596.x. Epub 2011 Sep 27. Review.

15.

Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.

Vasiljević N, Wu K, Brentnall AR, Kim DC, Thorat MA, Kudahetti SC, Mao X, Xue L, Yu Y, Shaw GL, Beltran L, Lu YJ, Berney DM, Cuzick J, Lorincz AT.

Dis Markers. 2011;30(4):151-61. doi: 10.3233/DMA-2011-0790.

16.

Augmented cecal mucosa appears pink under hexylaminolevulinate "blue light" fluorescence cystoscopy.

Tuffaha H, Shaw GL, Briggs T.

J Endourol. 2010 Jun;24(6):943-4. doi: 10.1089/end.2009.0569.

PMID:
20367243
17.

Flourescence cystoscopy--how to do it.

Shaw GL, Bunce CJ.

Photodiagnosis Photodyn Ther. 2008 Dec;5(4):267-70. doi: 10.1016/j.pdpdt.2009.01.007. Epub 2009 Feb 24. Review.

PMID:
19356669
18.

Transdermal oxybutynin: a review.

Shaw GL, Patel HR.

Expert Opin Drug Metab Toxicol. 2007 Jun;3(3):435-9. Review.

PMID:
17539749
19.

Sensitivity and specificity of the blankenship FCE system's indicators of submaximal effort.

Brubaker PN, Fearon FJ, Smith SM, McKibben RJ, Alday J, Andrews SS, Clarke E, Shaw GL Jr.

J Orthop Sports Phys Ther. 2007 Apr;37(4):161-8.

PMID:
17469668
20.

International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients.

Shaw GL, Wilson P, Cuzick J, Prowse DM, Goldenberg SL, Spry NA, Oliver T.

BJU Int. 2007 May;99(5):1056-65. Epub 2007 Mar 6. Review.

21.

Long-term enhancement of maze learning in mice via a generalized Mozart effect.

Aoun P, Jones T, Shaw GL, Bodner M.

Neurol Res. 2005 Dec;27(8):791-6.

PMID:
16354537
22.

Encrustation of biomaterials in the urinary tract.

Shaw GL, Choong SK, Fry C.

Urol Res. 2005 Feb;33(1):17-22. Epub 2004 Dec 22. Review.

PMID:
15614579
23.

Innate spatial-temporal reasoning and the identification of genius.

Peterson MR, Balzarini D, Bodner M, Jones EG, Phillips T, Richardson D, Shaw GL.

Neurol Res. 2004 Jan;26(1):2-8.

PMID:
14977052
24.

The Mozart Effect. To the Editor.

Shaw GL.

Epilepsy Behav. 2001 Dec;2(6):611-613. No abstract available.

PMID:
12609404
25.

FMRI study relevant to the Mozart effect: brain areas involved in spatial-temporal reasoning.

Bodner M, Muftuler LT, Nalcioglu O, Shaw GL.

Neurol Res. 2001 Oct;23(7):683-90.

PMID:
11680506
26.

Reliable short-term memory in the trion model: toward a cortical language and grammar.

Sardesai M, Figge C, Bodner M, Crosby M, Hansen J, Quillfeldt JA, Landau S, Ostling A, Vuong S, Shaw GL.

Biol Cybern. 2001 Mar;84(3):173-82.

PMID:
11252635
27.

Additional clues to lung cancer risk.

Shaw GL.

Cancer Invest. 1999;17(8):661-2. No abstract available.

PMID:
10592773
28.

Music enhances spatial-temporal reasoning: towards a neurophysiological basis using EEG.

Shaw GL, Bodner M.

Clin Electroencephalogr. 1999 Oct;30(4):151-5.

PMID:
10513321
29.

Detecting symmetric patterns in EEG data: a new method of analysis.

Bodner M, Shaw GL, Gabriel R, Johnson JK, Murias M, Swanson J.

Clin Electroencephalogr. 1999 Oct;30(4):143-50.

PMID:
10513320
30.

Enhanced learning of proportional math through music training and spatial-temporal training.

Graziano AB, Peterson M, Shaw GL.

Neurol Res. 1999 Mar;21(2):139-52.

PMID:
10100200
31.

Enhancement of spatial-temporal reasoning after a Mozart listening condition in Alzheimer's disease: a case study.

Johnson JK, Cotman CW, Tasaki CS, Shaw GL.

Neurol Res. 1998 Dec;20(8):666-72.

PMID:
9864729
32.

The "Mozart effect" on epileptiform activity.

Hughes JR, Daaboul Y, Fino JJ, Shaw GL.

Clin Electroencephalogr. 1998 Jul;29(3):109-19.

PMID:
9660010
33.

Key components of the Mozart effect.

Rauscher FH, Shaw GL.

Percept Mot Skills. 1998 Jun;86(3 Pt 1):835-41.

PMID:
9656277
34.

Synchronization between prefrontal and posterior association cortex during human working memory.

Sarnthein J, Petsche H, Rappelsberger P, Shaw GL, von Stein A.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7092-6.

35.

Genetic polymorphism of CYP2D6 and lung cancer risk.

Shaw GL, Falk RT, Frame JN, Weiffenbach B, Nesbitt JC, Pass HI, Caporaso NE, Moir DT, Tucker MA.

Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):215-9.

36.
37.

Symmetric temporal patterns in cortical spike trains during performance of a short-term memory task.

Bodner M, Zhou YD, Shaw GL, Fuster JM.

Neurol Res. 1997 Oct;19(5):509-14.

PMID:
9329028
38.

Measuring macromolecular diffusion using heteronuclear multiple-quantum pulsed-field-gradient NMR.

Dingley AJ, Mackay JP, Shaw GL, Hambly BD, King GF.

J Biomol NMR. 1997 Jul;10(1):1-8. doi: 10.1023/A:1018339526108.

PMID:
20683727
39.

Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.

Shaw GL, Weiffenbach B, Falk RT, Frame JN, Issaq HJ, Moir DT, Caporaso N.

Lung Cancer. 1997 May;17(1):61-8.

PMID:
9194027
40.

Persistent patterns of brain activity: an EEG coherence study of the positive effect of music on spatial-temporal reasoning.

Sarnthein J, vonStein A, Rappelsberger P, Petsche H, Rauscher FH, Shaw GL.

Neurol Res. 1997 Apr;19(2):107-16.

PMID:
9175137
41.

Intermediate Markers and Molecular Genetics of Lung Carcinogenesis.

Szabo E, Shaw GL.

Cancer Control. 1997 Mar;4(2):109-117.

PMID:
10763008
42.

Cancer Prevention: Perspectives and Implications.

Shaw GL.

Cancer Control. 1997 Mar;4(2):104-105. No abstract available.

PMID:
10763007
43.

Music training causes long-term enhancement of preschool children's spatial-temporal reasoning.

Rauscher FH, Shaw GL, Levine LJ, Wright EL, Dennis WR, Newcomb RL.

Neurol Res. 1997 Feb;19(1):2-8.

PMID:
9090630
44.

Improved search for elementary particles with fractional electric charge.

Mar NM, Lee ER, Fleming GR, Casey BC, Perl ML, Garwin EL, Hendricks CD, Lackner KS, Shaw GL.

Phys Rev D Part Fields. 1996 Jun;53(11):6017-6032. No abstract available.

PMID:
10019892
45.

Peptide amidating activity in human bronchoalveolar lavage fluid.

Scott FM, Treston AM, Shaw GL, Avis I, Sorenson J, Kelly K, Dempsey EC, Cantor AB, Tockman M, Mulshine JL.

Lung Cancer. 1996 Jun;14(2-3):239-51.

PMID:
8794407
46.

Backbone dynamics of the c-Jun leucine zipper: 15N NMR relaxation studies.

MacKay JP, Shaw GL, King GF.

Biochemistry. 1996 Apr 16;35(15):4867-77.

PMID:
8664278
47.

Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.

Shaw GL, Gazdar AF, Phelps R, Steinberg SM, Linnoila RI, Johnson BE, Oie HK, Russell EK, Ghosh BC, Pass HI, Minna JD, Mulshine JL, Ihde DC.

J Cell Biochem Suppl. 1996;24:173-85.

PMID:
8806100
48.

Minimisation of sensitivity losses due to the use of gradient pulses in triple-resonance NMR of proteins.

Stonehouse J, Clowes RT, Shaw GL, Keeler J, Laue ED.

J Biomol NMR. 1995 Apr;5(3):226-32. doi: 10.1007/BF00211750.

PMID:
22911500
49.

Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop.

Battey JF, Brown PH, Gritz ER, Hong WK, Johnson BE, Karp DD, Mulshine JL, Shaw GL, Shopland DR, Sunday ME, et al.

Lung Cancer. 1995 Mar;12(1-2):91-103. No abstract available.

PMID:
7600036

Supplemental Content

Support Center